{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:23:15Z","timestamp":1792664595274,"version":"4.5.0"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013072","name":"Major Science and Technology Project of Hainan Province","doi-asserted-by":"publisher","award":["ZDYF2024SHFZ099"],"award-info":[{"award-number":["ZDYF2024SHFZ099"]}],"id":[{"id":"10.13039\/501100013072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007935","name":"Hainan Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007935","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hainan Province","doi-asserted-by":"publisher","award":["825RC765"],"award-info":[{"award-number":["825RC765"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.critrevonc.2025.104999","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:09:04Z","timestamp":1761869344000},"page":"104999","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["The central role of IL-17 in cancer stemness and immune evasion: A novel axis for overcoming immune checkpoint inhibitor resistance"],"prefix":"10.1016","volume":"217","author":[{"given":"Shan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingsi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yage","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"38","key":"10.1016\/j.critrevonc.2025.104999_bib1","article-title":"Translational targeting of inflammation and fibrosis in frozen shoulder: molecular dissection of the T cell\/IL-17A axis","volume":"118","author":"Akbar","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104999_bib2","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jtho.2017.04.017","article-title":"Interleukin-17A promotes lung tumor progression through neutrophil attraction to tumor sites and mediating resistance to PD-1 blockade","volume":"12","author":"Akbay","year":"2017","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104999_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1104730","article-title":"PD-1 limits differentiation and plasticity of Tc17 cells","volume":"14","author":"Arra","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2025.104999_bib4","article-title":"Ovarian and endometrial endometrioid carcinoma following the use of a biologic IL-17 inhibitor","volume":"15","author":"Babcock","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.critrevonc.2025.104999_bib5","article-title":"The role of Interleukin 17 (IL17) in cancer: a systematic review","author":"Begagi\u0107","year":"2024","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.critrevonc.2025.104999_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.565470","article-title":"Much more than IL-17A: cytokines of the IL-17 family between microbiota and cancer","volume":"11","author":"Brevi","year":"2020","journal-title":"Front. Immunol."},{"issue":"46","key":"10.1016\/j.critrevonc.2025.104999_bib7","doi-asserted-by":"crossref","first-page":"24105","DOI":"10.1074\/jbc.M116.751263","article-title":"Hyaluronan production regulates metabolic and cancer stem-like properties of breast cancer cells via hexosamine biosynthetic pathway-coupled HIF-1 signaling","volume":"291","author":"Chanmee","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104999_bib8","article-title":"Interleukin-17\u2013induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer","volume":"217","author":"Chandra","year":"2020","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104999_bib9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ccell.2023.12.006","article-title":"Gut epithelial Interleukin-17 receptor A signaling can modulate distant tumors growth through microbial regulation","volume":"42","author":"Chandra","year":"2024","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104999_bib10","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s10067-019-04467-8","article-title":"Upregulated expression of STAT3\/IL-17 in patients with systemic lupus erythematosus","volume":"38","author":"Chen","year":"2019","journal-title":"Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104999_bib11","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1373234","article-title":"IL-17 induces antitumor immunity by promoting beneficial neutrophil recruitment and activation in esophageal squamous cell carcinoma","volume":"7","author":"Chen","year":"2017","journal-title":"Oncoimmunology"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104999_bib12","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210693","article-title":"IL-17-induced HIF1\u03b1 drives resistance to anti-PD-L1 via fibroblast-mediated immune exclusion","volume":"219","author":"Chen","year":"2022","journal-title":"J. Exp. Med."},{"issue":"22","key":"10.1016\/j.critrevonc.2025.104999_bib13","article-title":"Multifaceted pro-metastatic role of IL-17 signaling in modulating the tumor microenvironment of colorectal cancer","volume":"84","author":"Chojnacka","year":"2024","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2025.104999_bib14","series-title":"IL-17 in host defense","author":"Chu","year":"2017"},{"key":"10.1016\/j.critrevonc.2025.104999_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.actbio.2019.04.051","article-title":"Injectable biomaterials for delivery of interleukin-1 receptor antagonist: toward improving its therapeutic effect","volume":"93","author":"Clements","year":"2019","journal-title":"Acta Biomater."},{"issue":"33","key":"10.1016\/j.critrevonc.2025.104999_bib16","doi-asserted-by":"crossref","first-page":"19408","DOI":"10.1073\/pnas.2005010117","article-title":"CD4 T cell-intrinsic role for the T helper 17 signature cytokine IL-17: effector resistance to immune suppression","volume":"117","author":"Crawford","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.critrevonc.2025.104999_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111761","article-title":"Dynamic stromal cellular reaction throughout human colorectal adenoma\u2013carcinoma sequence: a role of TH17\/IL-17A","volume":"140","author":"Cui","year":"2021","journal-title":"Biomed. Pharm."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104999_bib18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/vaccines4030022","article-title":"The IL-8\/IL-8R axis: a double agent in tumor immune resistance","volume":"4","author":"David","year":"2016","journal-title":"Vaccines"},{"key":"10.1016\/j.critrevonc.2025.104999_bib19","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.4049\/jimmunol.1004021","article-title":"Generation of colitogenic Th17 CD4 T cells is enhanced by IL-17\u207a \u03b3\u03b4 T cells","volume":"186","author":"Do","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.critrevonc.2025.104999_bib20","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.4049\/jimmunol.1300527","article-title":"Mycobacteria-infected dendritic cells attract neutrophils that produce IL-10 and suppress Th17 cells","volume":"191","author":"Doz","year":"2013","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104999_bib21","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1080\/15412555.2017.1335697","article-title":"A randomized, placebo-controlled phase 2 trial of CNTO 6785 in chronic obstructive pulmonary disease","volume":"14","author":"Eich","year":"2017","journal-title":"COPD"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104999_bib22","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3390\/ijms17091433","article-title":"Targeting the tumor microenvironment: the protumor effects of IL-17 related to cancer type","volume":"17","author":"Fabre","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104999_bib23","first-page":"00088","article-title":"IL-17 and triple negative breast cancer","volume":"3","author":"Fabre","year":"2016","journal-title":"MOJ Immunol."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104999_bib24","first-page":"2211","article-title":"Safety, tolerability, and pharmacodynamics of ABT-122, a TNF- and IL-17\u2013targeted dual variable domain antibody, in rheumatoid arthritis","volume":"69","author":"Fleischmann","year":"2017","journal-title":"Arthritis Rheuma"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104999_bib25","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.7150\/ijbs.70408","article-title":"Interleukin-17 programs liver progenitor cell transformation into cancer stem cells through miR-122 downregulation with increased risk of primary liver cancer initiation","volume":"18","author":"Gasmi","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104999_bib26","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/art.40580","article-title":"ABT-122, a bispecific dual variable domain antibody targeting TNF and IL-17A, in patients with rheumatoid arthritis with inadequate response to methotrexate","volume":"70","author":"Genovese","year":"2018","journal-title":"Arthritis Rheuma"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104999_bib27","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s12094-013-1152-8","article-title":"Cell origins and significance of IL-17 in malignant pleural effusion","volume":"16","author":"Gong","year":"2014","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104999_bib28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fmed.2019.00113","article-title":"Monitoring patient response to pembrolizumab with peripheral blood exhaustion marker profiles","volume":"6","author":"Graves","year":"2019","journal-title":"Front. Med."},{"key":"10.1016\/j.critrevonc.2025.104999_bib29","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nature11465","article-title":"Adenoma-linked barrier defects and microbial products drive IL-23\/IL-17-mediated tumour growth","volume":"491","author":"Grivennikov","year":"2012","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104999_bib30","first-page":"1169","article-title":"Interleukin-17-induced EMT promotes lung cancer cell migration and invasion via NF-\u03baB\/ZEB1 signal pathway","volume":"5","author":"Gu","year":"2015","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.critrevonc.2025.104999_bib31","article-title":"Analysis of PD1, LAG3, TIGIT, and TIM3 expression in human lung adenocarcinoma reveals a 25-gene signature predicting immunotherapy response","volume":"5","author":"Gu\u00e9gan","year":"2024","journal-title":"Cell Rep. Med."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104999_bib32","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.4049\/jimmunol.0902574","article-title":"IL-17 promotes tumor development through the induction of tumor-promoting microenvironments at tumor sites and myeloid-derived suppressor cells","volume":"184","author":"He","year":"2010","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104999_bib33","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.4049\/jimmunol.2001223","article-title":"Identification of TRAF3IP2-AS1 as a regulator of IL-17 signaling through the SRSF10\u2013IRF1\u2013Act1 axis in autoimmune diseases","volume":"206","author":"He","year":"2021","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104999_bib34","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s41590-018-0071-9","article-title":"IL-17-receptor-associated adaptor Act1 directly stabilizes mRNAs to mediate IL-17 inflammatory signaling","volume":"19","author":"Herjan","year":"2018","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104999_bib35","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.18632\/oncotarget.1734","article-title":"Targeting aerobic glycolysis and HIF-1\u03b1 expression enhance imiquimod-induced apoptosis in cancer cells","volume":"5","author":"Huang","year":"2014","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104999_bib36","first-page":"1049","article-title":"Fake it \u2019til you make it: mast cells acquire IL-17 exogenously","volume":"100","author":"Huppler","year":"2016","journal-title":"J. Leukoc. Biol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104999_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002603","article-title":"Type 17 immunity promotes the exhaustion of CD8\u207a T cells in cancer","volume":"9","author":"Kim","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104999_bib38","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1158\/1538-7445.AM2023-5226","article-title":"Exome-wide association study identifies coding variant in IL17RA associated with survival in cancer patients treated with immunotherapy","volume":"83","author":"Kleeman","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2025.104999_bib39","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.2147\/DDDT.S105263","article-title":"Secukinumab for rheumatology: development and its potential place in therapy","volume":"10","author":"Koenders","year":"2016","journal-title":"Drug Des. Dev. Ther."},{"issue":"6605","key":"10.1016\/j.critrevonc.2025.104999_bib40","first-page":"eabj1234","article-title":"Interleukin-17 governs hypoxic adaptation of injured epithelium","volume":"377","author":"Konieczny","year":"2022","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104999_bib41","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jaci.2019.04.029","article-title":"IL-17A inhibition by secukinumab induces early clinical, histopathologic, and molecular resolution of psoriasis","volume":"144","author":"Krueger","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104999_bib42","first-page":"1290","article-title":"Visualization of IL-17A and IL-23 in inflammatory tissue using immuno-PET","volume":"62","author":"Krug","year":"2021","journal-title":"J. Nucl. Med."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104999_bib43","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1182\/blood-2008-09-177360","article-title":"Endogenous IL-17 contributes to reduced tumor growth and metastasis","volume":"114","author":"Kryczek","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104999_bib44","doi-asserted-by":"crossref","DOI":"10.4110\/in.2020.20.e6","article-title":"IL-17-producing cells in tumor immunity: Friends or foes?","volume":"20","author":"Kuen","year":"2020","journal-title":"Immune Netw."},{"issue":"25","key":"10.1016\/j.critrevonc.2025.104999_bib45","doi-asserted-by":"crossref","first-page":"34052","DOI":"10.18632\/oncotarget.8570","article-title":"HIF-1\u03b1 links mitochondrial perturbation to the dynamic acquisition of breast cancer tumorigenicity","volume":"7","author":"Kuo","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104999_bib46","doi-asserted-by":"crossref","first-page":"9874","DOI":"10.3390\/ijms24129874","article-title":"The role of IL-17 in the pathogenesis of oral squamous cell carcinoma","volume":"24","author":"Ladjevac","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2025.104999_bib47","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1158\/1538-7445.AM2015-441","article-title":"IL-17 and IL-17-producing cells associated with advanced stage or poor prognosis in oral cancers","volume":"75","author":"Lee","year":"2015","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104999_bib48","first-page":"177","article-title":"[Mechanism of IL-17 in colorectal inflammation-cancer transition]","volume":"38","author":"Li","year":"2022","journal-title":"Chin. J. Cell Mol. Immunol."},{"key":"10.1016\/j.critrevonc.2025.104999_bib49","article-title":"Cytokine expression of lung bacterial infection in newly diagnosed adult hematological malignancies","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104999_bib50","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-004308","article-title":"Successful management of pre-existing psoriatic arthritis through targeting the IL-23\/IL-17 axis in cancer patients receiving immune checkpoint inhibitor therapy: a case series","volume":"10","author":"Li","year":"2024","journal-title":"RMD Open"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104999_bib51","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1158\/1538-7445.AM2024-4073","article-title":"Abstract 4073: decoy-resistant IL-18 enhances checkpoint inhibitor combinations beyond anti-PD-1 in vitro and in vivo","volume":"84","author":"Lindquist","year":"2024","journal-title":"Cancer Res"},{"issue":"22","key":"10.1016\/j.critrevonc.2025.104999_bib52","doi-asserted-by":"crossref","first-page":"C007","DOI":"10.1158\/1538-7445.TUMBODY-C007","article-title":"Identifying the role of Interleukin-17 signaling in intestinal stem cells during pancreatic cancer","volume":"84","author":"Liu","year":"2024","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104999_bib53","first-page":"183","article-title":"Targeting the IL-17 receptor using liposomal spherical nucleic acids as topical therapy for psoriasis","volume":"140","author":"Liu","year":"2020","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104999_bib54","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001895","article-title":"Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer","volume":"9","author":"Liu","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"94","key":"10.1016\/j.critrevonc.2025.104999_bib55","first-page":"ra63","article-title":"Act1, a U-box E3 ubiquitin ligase for IL-17 signaling","volume":"2","author":"Liu","year":"2009","journal-title":"Sci. Signal"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104999_bib56","article-title":"High IL-17E and low IL-17C dermal expression identifies a fibrosis-specific motif common to morphea and systemic sclerosis","volume":"9","author":"Lonati","year":"2014","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104999_bib57","first-page":"1526","article-title":"Tc17 biology and function: novel concepts","volume":"50","author":"L\u00fcckel","year":"2020","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104999_bib58","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1080\/21655979.2021.1940622","article-title":"Self-assembled chitosan nanoparticles for intranasal delivery of recombinant protein interleukin-17 receptor C (IL-17RC): Preparation and evaluation in asthma mice","volume":"12","author":"Lv","year":"2021","journal-title":"Bioengineered"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104999_bib59","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2217\/imt-2021-0274","article-title":"Successful use of secukinumab in two melanoma patients with immune checkpoint inhibitor-induced inflammatory arthropathy","volume":"14","author":"Ma","year":"2022","journal-title":"Immunotherapy"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104999_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1348-0421.12560","article-title":"Interleukin-17 family cytokines in protective immunity against infections: role of hematopoietic and non-hematopoietic cell-derived interleukin-17s","volume":"62","author":"Matsuzaki","year":"2018","journal-title":"Microbiol. Immunol."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104999_bib61","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ccr.2014.03.014","article-title":"Oncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasia","volume":"25","author":"McAllister","year":"2014","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104999_bib62","doi-asserted-by":"crossref","first-page":"45","DOI":"10.5152\/tjg.2018.17114","article-title":"Expression of Th17\/Treg related molecules in gastric cancer tissues","volume":"29","author":"Meng","year":"2018","journal-title":"Turk. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104999_bib63","article-title":"Tumor-associated neutrophils suppress pro-tumoral IL-17\u207a \u03b3\u03b4 T cells through oxidative stress","volume":"16","author":"Mensurado","year":"2018","journal-title":"PLoS Biol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104999_bib64","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001358","article-title":"Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy","volume":"8","author":"Nagaoka","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104999_bib65","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/eji.200839120","article-title":"IL-17-producing \u03b3\u03b4 T cells","volume":"39","author":"O\u2019Brien","year":"2009","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104999_bib66","first-page":"619","article-title":"Dimethyl fumarate dampens IL-17\u2013Act1\u2013TBK1 axis-mediated phosphorylation of Regnase-1 and suppresses IL-17-induced I\u03baB-\u03b6 expression","volume":"519","author":"Ohgakiuchi","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"43","key":"10.1016\/j.critrevonc.2025.104999_bib67","doi-asserted-by":"crossref","first-page":"32751","DOI":"10.1074\/jbc.M110.121418","article-title":"SEF\/IL-17R (SEFIR) is not enough: an extended SEFIR domain is required for IL-17RA-mediated signal transduction","volume":"285","author":"Onishi","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104999_bib68","first-page":"270","article-title":"The dual role of interleukin-17 in the growth of human cervical cancer cells","volume":"24","author":"Pan","year":"2022","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104999_bib69","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2567.2011.03465.x","article-title":"The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases","volume":"134","author":"Pappu","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.critrevonc.2025.104999_bib70","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1038\/s41467-021-22875-w","article-title":"Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS\/p53 mutant lung cancers","volume":"12","author":"Peng","year":"2021","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104999_bib71","article-title":"Angels and demons: Th17 cells represent a beneficial response, while neutrophil IL-17 is associated with poor prognosis in squamous cervical cancer","volume":"4","author":"Punt","year":"2015","journal-title":"Oncoimmunology"},{"issue":"31","key":"10.1016\/j.critrevonc.2025.104999_bib72","first-page":"E3562","article-title":"Murine CD27(\u2013) V\u03b36(+) \u03b3\u03b4 T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophages","volume":"111","author":"Rei","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104999_bib73","first-page":"424","article-title":"Evaluation of the intracellular expression of interleukin 17 in patients with ovarian cancer","volume":"83","author":"Rogala","year":"2012","journal-title":"Ginekol. Pol."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104999_bib74","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1084\/jem.191.7.1233","article-title":"Requirement of tumor necrosis factor receptor\u2013associated factor (TRAF)6 in interleukin 17 signal transduction","volume":"191","author":"Schwandner","year":"2000","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104999_bib75","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/cmi.2017.12","article-title":"IL-17-triggered downregulation of miR-497 results in high HIF-1\u03b1 expression and consequent IL-1\u03b2 and IL-6 production by astrocytes in EAE mice","volume":"14","author":"Shan","year":"2017","journal-title":"Cell. Mol. Immunol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104999_bib76","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2025.104999_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108963","article-title":"Anti-IL-17A ssDNA aptamer ameliorated psoriasis skin lesions in the imiquimod-induced psoriasis mouse model","volume":"110","author":"Shobeiri","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104999_bib78","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/19420862.2015.1093266","article-title":"Discovery and characterization of COVA322, a clinical-stage bispecific TNF\/IL-17A inhibitor for the treatment of inflammatory diseases","volume":"8","author":"Silacci","year":"2015","journal-title":"mAbs"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104999_bib79","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.immuni.2013.11.018","article-title":"Alterations in the microbiota drive interleukin-17C production from intestinal epithelial cells to promote tumorigenesis","volume":"40","author":"Song","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.critrevonc.2025.104999_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111601","article-title":"Pathogenic Th17 cell-mediated liver fibrosis contributes to resistance to PD-L1 antibody immunotherapy in hepatocellular carcinoma","volume":"129","author":"Song","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.critrevonc.2025.104999_bib81","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1476-4598-12-78","article-title":"TNF\u03b1 and IL-17 cooperatively stimulate glucose metabolism and growth factor production in human colorectal cancer cells","volume":"12","author":"Straus","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104999_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1408710","article-title":"Interleukin-17 directly stimulates tumor infiltrating Tregs to prevent cancer development","volume":"15","author":"Theune","year":"2024","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104999_bib83","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4103\/MJBL.MJBL_26_18","article-title":"Increased transforming growth factor-\u03b2 and interleukin-17 transcripts in peripheral blood of breast cancer patients with different clinical stages","volume":"15","author":"Touma","year":"2018","journal-title":"Med. J. Babylon."},{"issue":"13","key":"10.1016\/j.critrevonc.2025.104999_bib84","doi-asserted-by":"crossref","first-page":"5065","DOI":"10.1158\/1538-7445.AM2018-5065","article-title":"Cancer-derived Escherichia coli induces tumor-promoting inflammatory cytokine IL-6 in cancer-associated fibroblasts (CAFs) in a NF-\u03baB\/BRD4 dependent manner","volume":"78","author":"Uribe","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2025.104999_bib85","first-page":"1287","article-title":"Pre-clinical proof-of-concept of ALX-0761, a Nanobody\u00ae neutralizing both IL-17A and IL-17F in a cynomolgus monkey collagen-induced arthritis model","volume":"65","author":"Vanheusden","year":"2013","journal-title":"Arthritis Rheuma"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104999_bib86","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.immuni.2014.11.009","article-title":"Interleukin-17 receptor A signaling in transformed enterocytes promotes early colorectal tumorigenesis","volume":"41","author":"Wang","year":"2014","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104999_bib87","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.tranon.2019.04.023","article-title":"IL-17A increases multiple myeloma cell viability by positively regulating Syk expression","volume":"12","author":"Wang","year":"2019","journal-title":"Transl. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104999_bib88","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3233\/CBM-203092","article-title":"Targeting IL-17alpha to promote anti-PD-1 therapy effect by screening the tumor immune microenvironment in a mouse oral carcinogenesis model","volume":"31","author":"Wang","year":"2021","journal-title":"Cancer Biomark."},{"key":"10.1016\/j.critrevonc.2025.104999_bib89","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/804347","article-title":"Interleukin-17 could promote breast cancer progression at several stages of the disease","volume":"2015","author":"Welte","year":"2015","journal-title":"Mediat. Inflamm."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104999_bib90","first-page":"1820","article-title":"Interleukin-17\u2013CXCR2 axis facilitates breast cancer progression by up-regulating neutrophil recruitment","volume":"189","author":"Wu","year":"2019","journal-title":"Am. J. Pathol."},{"issue":"611","key":"10.1016\/j.critrevonc.2025.104999_bib91","article-title":"Characterization of initial key steps of IL-17 receptor B oncogenic signaling for targeted therapy of pancreatic cancer","volume":"13","author":"Wu","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104999_bib92","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.immuni.2014.03.013","article-title":"\u03b3\u03b4T17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer","volume":"40","author":"Wu","year":"2014","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104999_bib93","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/onc.2013.537","article-title":"Interleukin-17 produced by tumor microenvironment promotes self-renewal of CD133\u207a cancer stem-like cells in ovarian cancer","volume":"34","author":"Xiang","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2025.104999_bib94","first-page":"6591785","article-title":"Distribution and clinical significance of IL-17A-producing T cells in patients with non-small cell lung cancer","volume":"2022","author":"Xu","year":"2022","journal-title":"J. Immunol. Res."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104999_bib95","doi-asserted-by":"crossref","first-page":"7128","DOI":"10.4049\/jimmunol.179.10.7128","article-title":"IL-17B and IL-17C are associated with TNF-\u03b1 production and contribute to the exacerbation of inflammatory arthritis","volume":"179","author":"Yamaguchi","year":"2007","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104999_bib96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1586\/1744666X.2016.1112739","article-title":"Interleukin 17A inhibition in the treatment of psoriasis","volume":"12","author":"Yiu","year":"2016","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.critrevonc.2025.104999_bib97","article-title":"The role of Treg cells in colorectal cancer and the immunotherapy targeting Treg cells","volume":"16","author":"Y\u00fc","year":"2025","journal-title":"Front. Immunol."},{"issue":"22","key":"10.1016\/j.critrevonc.2025.104999_bib98","article-title":"Interleukin 17\u2013induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer","volume":"80","author":"Zhang","year":"2020","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2025.104999_bib99","doi-asserted-by":"crossref","first-page":"1479505","DOI":"10.3389\/fimmu.2024.1479505","article-title":"The role of interleukin-17 in inflammation-related cancers","volume":"15","author":"Zhang","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104999_bib100","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ccell.2023.12.006","article-title":"Gut epithelial Interleukin-17 receptor A signaling can modulate distant tumors growth through microbial regulation","volume":"42","author":"Zhang","year":"2024","journal-title":"Cancer Cell"},{"issue":"14","key":"10.1016\/j.critrevonc.2025.104999_bib101","doi-asserted-by":"crossref","first-page":"877","DOI":"10.21037\/atm-20-4843","article-title":"Cancer-associated fibroblasts promote the migration and invasion of gastric cancer cells via activating IL-17a\/JAK2\/STAT3 signaling","volume":"8","author":"Zhang","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.critrevonc.2025.104999_bib102","article-title":"High HPK1\u207aPD-1\u207aTIM-3\u207aCD8\u207a T cells infiltration predicts poor prognosis to immunotherapy in NSCLC patients","volume":"127","author":"Zhang","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.critrevonc.2025.104999_bib103","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1158\/1538-7445.AM2016-1447","article-title":"Influence of IL-17-secreting immune cells in pancreatic cancer stemness","volume":"76","author":"Zhang","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2025.104999_bib104","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.2147\/TCRM.S184809","article-title":"Increased IL-17-producing CD8+ T cell frequency predicts short-term mortality in patients with hepatitis B virus-related acute-on-chronic liver failure","volume":"14","author":"Zhang","year":"2018","journal-title":"Ther. Clin. Risk Manag"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104999_bib105","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1053\/j.gastro.2018.03.041","article-title":"Immune cell production of interleukin 17 induces stem cell features of pancreatic intraepithelial neoplasia cells","volume":"155","author":"Zhang","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.critrevonc.2025.104999_bib106","article-title":"Bio-imaging and photodynamic therapy with tetra sulphonatophenyl porphyrin (TSPP)-TiO\u2082 nanowhiskers: New approaches in rheumatoid arthritis theranostics","volume":"5","author":"Zhao","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2025.104999_bib107","article-title":"Acquired resistance to immune checkpoint blockades: the underlying mechanisms and potential strategies","volume":"12","author":"Zhou","year":"2021","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104999_bib108","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.2337\/db19-0592","article-title":"Longitudinal analysis of serum cytokine levels and gut microbial abundance links IL-17\/IL-22 with Clostridia and insulin sensitivity in humans","volume":"69","author":"Zhou","year":"2020","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104999_bib109","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1053\/j.gastro.2012.06.010","article-title":"CD8\u207a T cells that produce interleukin-17 regulate myeloid-derived suppressor cells and are associated with survival time of patients with gastric cancer","volume":"143","author":"Zhuang","year":"2012","journal-title":"Gastroenterology"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825003877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825003877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:27:54Z","timestamp":1773833274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842825003877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":109,"alternative-id":["S1040842825003877"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104999","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The central role of IL-17 in cancer stemness and immune evasion: A novel axis for overcoming immune checkpoint inhibitor resistance","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104999","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104999"}}